A new second generation HPMC capsule has been developed to speed formulation and commercialization timelines in pharmaceutical drug development. Vcaps Plus capsules developed without gelling agents provide HPMC capsules with improved physical and operational performance to match the needs of the pharmaceutical industry. This presentation will review the studies that demonstrate superior performance over traditional HPMC capsules and demonstrate how these capsules, now in use at many major pharmaceutical companies, can optimize product performance and improve product stability as well as reduce development timelines.
Business Development Manager, EMEA
Quality Assurance Engineer